Search
for
Sort by
Research 121–150 of 1000+
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Prevention and treatment of experimental prostate cancer in lobund-wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Redefining hormone resistance in prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Finasteride and prostate cancer
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Risk factors for prostate cancer: a case-control study in Greece
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
- Management of Advanced Prostate Cancer Undergoing Major Shift
- Urological Oncology: Prostate Cancer